End-Stage Renal Disease
The mechanisms and pathophysiology of kidney failure and the progression of chronic kidney disease to kidney failure.
The End-Stage Renal Disease (ESRD) program promotes basic, translational, and clinical research to reduce morbidity and mortality from kidney failure or ESRD and to improve the effectiveness of dialysis and transplantation. The portfolio includes studies on factors associated with fistula maturation, complications of grafts for vascular access, appropriate dialysis dose, and infectious complications in peritoneal dialysis. Studies also are promoted on the causes and prevention of progressive loss of kidney function in long-term kidney transplant recipients; organ procurement; and methods for making organs more available (including organ storage and preservation); non-immune kidney allograft dysfunction; and chronic rejection.
NIDDK Program Staff
- Kevin Abbott, M.D., M.P.H. Kidney and Urology Epidemiology; Transplant, including transplant related clinical trials; Dialysis Clinical Studies, non interventional, no clinical trials
Recent Funding OpportunitiesView More Recent Funding Opportunities
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
Notice of Special Interest: Kidney Precision Medicine Technology Development and Translation
NIDDK carries forward the activities developed under NKDEP to meet ongoing need.
View related clinical trials from ClinicalTrials.gov.
Study sections conduct initial peer review of applications in a designated scientific area. Visit the NIH’s Center for Scientific Review website to search for study sections.
NIDDK makes publicly supported resources, data sets, and studies available to researchers to accelerate the rate and lower the cost of new discoveries.
- Ancillary Studies to Major Ongoing Clinical Studies to extend our knowledge of the diseases being studied by the parent study investigators under a defined protocol or to study diseases and conditions not within the original scope of the parent study but within the mission of the NIDDK.
- NIDDK Central Repository for access to clinical resources including data and biospecimens from NIDDK-funded studies.
- NIDDK Information Network (dkNET) for simultaneous search of digital resources, including multiple datasets and biomedical resources relevant to the mission of the NIDDK.
Additional Research Programs
NIDDK supports the training and career development of medical and graduate students, postdoctoral fellows, and physician scientists through institutional and individual grants.Learn about NIDDK Research Training Programs
The NIDDK offers and participates in a variety of opportunities for trainees and researchers from communities underrepresented in the biomedical research enterprise. These opportunities include travel and scholarship awards, research supplements, small clinical grants, high school and undergraduate programs, and a network of minority health research investigators.Learn about NIDDK Diversity Programs
NIDDK participates in the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. These programs support innovative research conducted by small businesses that has the potential for commercialization.Learn about NIDDK Small Business Programs
Human Subjects Research
NIDDK provides funding for pivotal clinical research, from preliminary clinical feasibility to large multi-center studies.Learn about Human Subjects Research
NIDDK provides funding opportunities and resources to encourage translation of basic discoveries into novel therapeutics.Learn about NIDDK Translational Research Opportunities
Meetings & Workshops
Supports researchers with tools to enhance scientific rigor, reproducibility, and transparency, and provides a big data knowledge base for genomic and pathway hypothesis generation.
Providing education and training for the next generation of biomedical and behavioral scientist